Sarveshwar Foods Limited (SFL), an ISO 22000:2018 and USFDA-certified company in the agro-product FMCG sector, showcased robust financial performance during the July–September quarter of FY27. The company’s revenue from operations surged by 12% to ₹714.13 Cr, while the profit after tax (PAT) increased by 9% to ₹16.61 Cr, reflecting its strategic expansion and operational efficiency.

Operational Resilience

The growth momentum was supported by a robust order pipeline across domestic and international markets, strategic expansion initiatives, and a consistent focus on quality and customer satisfaction. SFL’s emphasis on operational excellence, product quality, and market expansion has strengthened its business fundamentals and competitive positioning.

Market Diversification

The growing demand for premium-quality rice, organic products, and value-added food offerings across domestic and international markets presents significant growth opportunities. The company’s diversified product portfolio, strong sourcing network, and expanding distribution reach remain key drivers of its growth. SFL continues to focus on enhancing operational efficiencies, expanding its export footprint, and investing in brand development and product innovation.

As we enter the second half of FY27, SFL remains committed to driving profitable growth, strengthening customer relationships, and creating sustainable long-term value for all stakeholders. Mr. Anil Kumar, Managing Director, Sarveshwar Group, expressed his satisfaction with the company’s resilience and strategic progress, thanking stakeholders for their continued trust and support.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Sarveshwar Foods Limited

Sarveshwar Foods Limited belongs to the Consumer Defensive › Packaged Foods sector. Here’s a quick read on where the business and the stock stand today.

Sarveshwar posts a 8.1% three-month gain, but softens in the last few weeks. The PEG of 0.22 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. The stock gives back 0.5% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Both the business and the stock move in the right direction. Revenue grows at 25.0%, profits at 59.8%, and the PEG sits at 0.22 — below its growth rate. That combination is rare. Check Fundamentals of Sarveshwar Foods Limited.

Piccadily Agro Industries Limited (PAIL), one of India’s leading producers of premium alcoholic beverages, announced its financial results for the quarter ended September 30, 2026. The Company reported a revenue from operations of INR 277.9 crore in Q2 FY27, up 19.4% YoY from INR 232.7 crore in the corresponding quarter last year, driven by continued momentum in its Distillery business. Distillery revenue increased 30.5% YoY to INR 271.3 crore and accounted for 97.6% of the Company’s quarterly revenue, compared with 89.3% in Q2 FY26.

Distillery Performance

The Distillery business remains the principal growth engine, with its increasing contribution reflecting the progress made in strengthening Piccadily’s spirits-led business. The scaling up of the Chhattisgarh Distillery, together with enhanced manufacturing capabilities, positions the company well to support long-term growth ambitions.

Product Innovation and Expansion

The Company continues to advance its strategic focus on strengthening its premium, super-premium, and luxury spirits portfolio, expanding market presence and distribution, enhancing brand equity, and leveraging its expanded manufacturing capabilities to drive sustainable long-term growth. Recent product introductions, including Indri Ilika, Indri Agneya, and the Diwali Collector’s Edition 2026, further reinforce the depth and premium positioning of its portfolio.

Future Outlook

Commenting on the results, Mr. Natwar Agarwal, Chief Financial Officer, Piccadily Agro Industries Limited, said, “Q2 FY27 saw continued momentum in our core Distillery business, which grew over 30% YoY, while overall Company revenue increased by 19.4%. Our H1 FY27 PAT is higher than the corresponding period last year, reflecting the underlying strength of our business and continued progress towards our financial objectives. The Company remains firmly on track to achieve its business objectives, with a continued focus on building differentiated brands, expanding its distribution footprint, strengthening manufacturing capabilities, and deepening its presence across domestic and international markets.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Piccadily Agro Industries Limited

Piccadily Agro Industries Limited belongs to the Consumer Defensive › Beverages – Wineries & Distilleries sector. Here’s a quick read on where the business and the stock stand today.

Piccadily moves sideways over three months, with neither buyers nor sellers taking control. The PEG of 0.49 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. The business compounds revenue at 19.5% and profits at 83.3% CAGR. That is strong double-digit growth on both counts. The stock gains 3.6% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 19.5% and profits at 83.3% CAGR, with D/E of 0.00. Meanwhile, the stock dips 7.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Piccadily Agro Industries Limited.

Procter & Gamble Hygiene and Health Care Ltd. (PGHH) today announced its financial results for the second quarter ended September 30, 2026. The company reported sales of ₹ 1145 crores, flat versus the same quarter last year. Profit After Tax (PAT) was reported at ₹196 crores, down 7% versus the same period last year.

Impact of Cost Fluctuations

In the quarter, the company experienced a double-digit impact on profitability driven by commodity cost fluctuations and headwinds like raw material and energy costs, as well as unfavorable foreign exchange rates. However, a significant portion of this was offset by the robust productivity program.

Strategic Investments

In the quarter, the company also continued to significantly invest back in innovation and advertising & promotion (versus past quarter) – in an endeavor to position the company for long-term competitiveness and value creation.

Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “We continue to invest strategically in our brands, innovation and market capabilities, even as the macro-economic landscape remains challenging. We continue to believe that our strategic priorities, combined with the strength of our brands and organizational capabilities, position us well to leverage future growth opportunities and create sustainable long-term value for all our stakeholders. We are excited about the future.”

The first half of FY 2026–27 was marked by sustained innovation across our vectors of superiority. Key milestones include the launches of the upgraded Vicks ZzzQuil with Ashwagandha and Vicks medicated lozenges, alongside the ongoing evolution of our media model to better engage consumers where they are. The Company continues to focus on, and drive, Whisper Period Pants to delight consumers with 360-degree leakage protection.

As we look ahead, we remain committed to our Integrated Growth Strategy, focusing on a focused product portfolio of daily use categories where performance drives brand choice, superiority, productivity, constructive disruption, and an agile and accountable organization to deliver balanced growth and value creation.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.

Procter drops 15.1% over three months and trades near its 52-week lows. D/E sits at 0.00 with a 3.22% dividend and unbroken revenue growth. Financial stability is a genuine strength. The PEG of 2.08 is on the high side. However, it is acceptable for a quality compounder with a strong moat. Sellers drive 2.6x the volume of buyers. Furthermore, they controlled 18 of recent sessions versus 12 for buyers — a clear distribution signal. The business compounds at 4.1% revenue and 14.2% profit CAGR, with D/E of 0.00. Yet the stock drops 15.1% in three months. The business does not deteriorate — the stock does. That gap is what long-term investors look for. Check Fundamentals of Procter & Gamble Hygiene and Health Care Limited.